Table: begin end state 1 18 cytoplasmic 19 36 transmembrane 37 58 non-cytoplasmic 59 78 transmembrane 79 87 cytoplasmic 88 108 transmembrane 109 113 non-cytoplasmic 114 135 transmembrane 136 168 cytoplasmic 169 191 transmembrane 192 196 non-cytoplasmic 197 217 transmembrane 218 266 cytoplasmic 267 287 transmembrane 288 306 non-cytoplasmic 307 329 transmembrane 330 340 cytoplasmic 341 359 transmembrane 360 363 non-cytoplasmic 364 385 transmembrane 386 396 cytoplasmic 397 422 transmembrane 423 434 non-cytoplasmic 435 454 transmembrane 455 467 cytoplasmic
Input: >GFF2889 MNLNEPINAHRVGQAVGNYRWTICAMLFFATTVNYLDRQVLSLLAPQLSTQFGWSNTDYA NIAAVFQFVYAISMLFAGRFVDKIGTKAAYVVAIAIWSTGAIMHAFSVPMGEGIAAISGA IGLAVIPVSIAGFMLSRAVLAIGEAGNFPIAIKATAEYFPKKERSLATGIFNSGANVGAI LAPICVPLIAGLWGWEAAFIVIGGLGFVWVVVWIALYQKPEEQKRLSPEELAYIRSDQTV QPFTPAPAGAPEKKVSWFKLLTYRQTWAFAFGKFMTDGVWWFFLFWLPTYLSAQYGMKGA DIVMPLAVLYSMTMVGSIGGGWFPSYFMARGDAPYDGRMKAMLVIALFPLVVLLAQPLGY ISFWVPVLLIGVGASAHQAWSCNIFTTVSDMFPQKTVASVVGIGGMAGGLGGVVMTKIGG WVFDYYKSVGDIHTGYMIMFAICALAYLVAWSVMKTLVPRHKEITDL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server